
Gainers
- Armstrong Flooring, Inc. (NYSE:AFI) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company.
- Regulus Therapeutics Inc. (NASDAQ:RGLS) surged 54.8% to close at $0.2660 after the company announced the FDA has accepted its Investigational New Drug Application for RGLS8429 for the treatment of Autosomal Dominant Polycystic Kidney Disease.
- Sunlands Technology Group (NYSE:STG) rose 34.3% to settle at $3.29.
- Trecora Resources (NYSE:TREC) shares gained 26% to close at $9.51 on Wednesday as the company agreed to be acquired by an affiliate of Balmoral Funds at $9.81 per share in cash or an enterprise value of $247 million.
- Golden Matrix Group, Inc. (NASDAQ:GMGI) rose 23.9% to settle at $4.25.
- Charge Enterprises, Inc. (NASDAQ:CRGE) gained 22.1% to close at $3.65.
- Inspired Entertainment, Inc. (NASDAQ:INSE) jumped 21.3% to close at $10.65 after the company reported better-than-expected Q1 EPS and sales results and approved a $25 million.
- Regis Corporation (NYSE:RGS) gained 20.1% to close at $0.8901. Regis recently reported worse-than-expected Q3 EPS and sales results.
- H&R Block, Inc. (NYSE:HRB) gained 19.5% to close at $28.41 as the company posted upbeat Q3 results and raised FY22 sales guidance.
- Blue Water Vaccines, Inc. (NASDAQ:BWV) jumped 18.5% to close at $6.01. Blue Water Vaccines reported expanded license deal with St. Jude Children's Hospital for novel bacterial vaccine platform.
- Alpha Teknova, Inc. (NASDAQ:TKNO) gained 17% to settle at $12.16. Alpha Teknova posted Q1 sales of $11.10 million.
- AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC) jumped 16.4% to close at $0.30. AnPac Bio regained compliance with market-value-of-publicly held shares requirement upon transfer to the Nasdaq Capital Market.
- BioSig Technologies, Inc. (NASDAQ:BSGM) gained 16.3% to settle at $1.00.
- TORM plc (NASDAQ:TRMD) surged 16.2% to close at $11.35.
- Embark Technology, Inc. (NASDAQ:EMBK) gained 16.1% to close at $1.66. Embark Technology posted a Q1 loss of $0.04 per share.
- GlucoTrack, Inc. (NASDAQ:GCTK) rose 15.9% to close at $2.85.
- Celsius Holdings, Inc. (NASDAQ:CELH) jumped 14.8% to close at $47.42 after the company reported better-than-expected Q1 sales results.
- Grocery Outlet Holding Corp. (NASDAQ:GO) surged 14.7% to settle at $35.65 after the company reported better-than-expected Q1 EPS and sales results.
- Sylvamo Corporation (NYSE:SLVM) gained 14.7% to close at $44.68 following Q1 results.
- Renovacor, Inc. (NYSE:RCOR) rose 13.3% to close at $2.72.
- Borr Drilling Limited (NYSE:BORR) jumped 10.6% to settle at $4.38.
- Callaway Golf Company (NYSE:ELY) surged 10.2% to settle at $19.80 after the company reported better-than-expected Q1 EPS and sales results and issued FY22 revenue guidance above analyst estimates.
- Switch, Inc. (NYSE:SWCH) rose 9.1% to close at $33.54 after the company announced it will be taken private by DigitalBridge Investment Management and IFM in an $11 billion transaction.
- Desktop Metal, Inc. (NYSE:DM) rose 8.3% to close at $1.44. Desktop Metal priced its $100 million convertible senior notes offering.
- Electronic Arts Inc. (NASDAQ:EA) gained 8% to close at $120.49 after the company reported Q4 financial results and issued FY23 guidance.
- Endeavour Silver Corp. (NYSE:EXK) surged 7.7% to close at $3.34 following upbeat quarterly results.
- INNOVATE Corp. (NYSE:VATE) gained 7.4% to close at $2.48. Innovate recently posted Q1 loss of $0.18 per share.
- Exicure, Inc. (NASDAQ:XCUR) gained 7.2% to close at $0.1140 after the company reported a $5 million raise in private placement transaction priced at market premium.
- Ferroglobe PLC (NASDAQ:GSM) gained 6.6% to close at $6.78 after the company reported better-than-expected Q1 EPS results.
- Organogenesis Holdings Inc. (NASDAQ:ORGO) gained 6.3% to close at $5.88 following Q1 results.
- Electra Battery Materials Corporation (NASDAQ:ELBM) shares rose 5.7% to close at $3.93 after the company issued an an Update on its Cobalt-Copper Mineral Project in Idaho.
- Veru Inc. (NASDAQ:VERU) rose 4.8% to $8.16. In a Pre-EUA meeting, FDA said Veru should submit a request for FDA emergency use authorization for sabizabulin in hospitalized COVID-19 patients.